Tolerability and activity of ublituximab, umbralisib, and ibrutinib in patients with chronic lymphocytic leukaemia and non-Hodgkin lymphoma: a phase 1 dose escalation and expansion trial
| Image |  |
|---|---|
| Description | scientific article published on 01 February 2019 |
| Author/s |
author: Loretta J Nastoupil Tanya Siddiqi |
| Publication date | February 1, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |